{
    "organizations": [],
    "uuid": "a9779ca735711258abe13c6a67a08bfe2226119f",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-cerenis-therapeutics-holding-creat/brief-cerenis-therapeutics-holding-creation-of-scientific-advisory-board-in-oncology-idUSFWN1S912U",
    "ord_in_thread": 0,
    "title": "BRIEF-Cerenis Therapeutics Holding: Creation Of Scientific Advisory Board In Oncology",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 2 (Reuters) - CERENIS THERAPEUTICS HOLDING SA :\n* CREATION OF ITS SCIENTIFIC ADVISORY BOARD IN ONCOLOGY (SAB-ONCOLOGY)\n* BRIGGS MORRISON, MD, WILL SERVE AS CHAIRMAN OF SAB * SAB-ONCOLOGY WILL WORK CLOSELY WITH CERENISâ€™ MANAGEMENT TEAM Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-05-03T00:25:00.000+03:00",
    "crawled": "2018-05-03T12:08:51.003+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "cerenis",
        "therapeutic",
        "holding",
        "sa",
        "creation",
        "scientific",
        "advisory",
        "board",
        "oncology",
        "briggs",
        "morrison",
        "md",
        "serve",
        "chairman",
        "sab",
        "work",
        "closely",
        "cerenis",
        "management",
        "team",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}